Six RNAi-Related Patent Applications Published by the US Patent Office

Sep 03, 2004

Premium

Title: Covalent Modification of RNA for In Vitro and In Vivo Delivery. Number: 20040167090. Filed: Feb. 19, 2004. Lead Inventor: Sean Monahan, Mirus.

According to the patent application’s abstract, the invention comprises “post-synthetic modification of RNA for the delivery of the RNA to a mammalian cell. The modifications enhance [resistance] of the RNA to nuclease digestion, and [enhance] delivery of the RNA to the cell whether the RNA is delivered alone or in combination with a transfection agent,” it states.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

How to Perform Successful CRISPR Experiments

High Throughput RT-qPCR for Gene Expression Analysis

Jun

19

Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Main menu